IMARC Group, a leading market research company, has recently releases report titled Women's Health Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. The study provides a detailed analysis of the industry, including the global women's health diagnostics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is thewomen's health diagnostics market?

The globalwomen's health diagnostics market sizereachedUS$ 23.6 Billion in 2022. Looking forward, IMARC Group expects the market to reachUS$ 37.3 Billion by 2028, exhibiting agrowth rate (CAGR) of 7.51%during 2023-2028.

What are Women's Health Diagnostics?

Womens health diagnostics are the medical tests and procedures that are specially designed for monitoring and screening the health of women. They comprise various testing solutions, such as ultrasound, magnetic resonance imaging (MRI), mammography, biopsy, bone density scan, pelvic exam, and computed tomography (CT). They benefit in diagnosing and treating urological disorders, autoimmune diseases, pregnancy, menstrual problems, and ovarian, breast, and cervical cancer. Besides this, they aid in detecting several disorders and preventing complications while improving the life of women.

Request Free Sample Copy of This Report:https://www.imarcgroup.com/womens-health-diagnostics-market/requestsample

What are the growth prospects and trends in thewomen's health diagnostics industry?

At present, the increasing incidence of numerous lifestyles and chronic disorders among women represents one of the major factors impelling the growth of the market. Additionally, the rising number of diagnostic and imaging centers across the globe is bolstering the growth of the market.

Apart from this, the growing demand for womens health diagnostics due to the increasing health consciousness and awareness about early diagnosis is offering a positive market outlook. Moreover, the rising prevalence of infectious diseases, such as human immunodeficiency viruses (HIV) and hepatitis, is creating lucrative growth opportunities for industry investors.

Besides this, the increasing demand for minimally invasive treatment solutions that provide a faster and enhanced diagnosis is propelling the market growth. Furthermore, governing agencies of various countries are promoting womens health awareness, which is contributing to the growth of the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

• Diagnostic Devices
  • Biopsy Device
  • Imaging and Monitoring Devices
  • Accessories and Consumables
• Diagnostic Tests
  • Breast Cancer Testing
  • PAP Smear and HPV Test
  • Pregnancy Testing and Ovulation Testing
  • Others

Breakup by Application:

• Breast Cancer
• Infectious Disease Testing
• Osteoporosis Testing
• Pregnancy and Fertility Testing
• Sexually Transmitted Disease Testing
• Others

Breakup by End User:

• Hospital and Diagnostics Centers
• Home Care

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Abbott Laboratories, Becton Dickinson and Company, bioMrieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Groups information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email:sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/